From: Nadroparine calcium or enoxaparine in acute coronary syndrome patients suffering renal insufficiency: The nadroparin versus enoxaparin (NaVe) study design
Group 1 Enoxaparin
Group 2 Nadroparine Calcium
Subcutaneous injection at:
Day 1
Hour 8 – 16 – 20
Day 3
Blood samples taken at:
Hour 11 PM
Hour 6 AM